Ozempic 3.0? This drug causes the greatest weight loss — by far
Ozempic 3.0? Retatrutide — an experimental drug nicknamed “triple G” — could be your best shot at a slimmer waistline when it ...
Novo Nordisk Pushes FDA To Exclude Compounding For Its Early-Generation Diabetes Drug
Danish pharmaceutical giant Novo Nordisk A/S (NYSE:NVO) submitted a Citizen Petition to the FDA requesting the exclusion of ...
FiercePharma3d
Novo asks FDA to restrict Victoza compounding amid GLP-1 outsourcing row
In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies ...
조선일보11d
FDA approves generic Victoza, expects improved supply of obesity drug Saxenda
It is expected that the FDA will soon approve this generic as an obesity treatment since the obesity drug Saxenda has the ...
Tyler Morning Telegraph12d
Medicaid Now Covers GLP-1s for Obesity in Texas
or Saxenda). Amid the Biden administration’s recent proposal to expand obesity drug coverage under Medicare and Medicaid, ...
Opelika Observer6d
Medicaid now covers GLP-1s for obesity in Alabama
Alabama now provides partial GLP-1 coverage for obesity: Among the obesity-indicated GLP-1s, Medicaid in Alabama covers just ...
The Victoria Advocate12d
Medicaid Now Covers GLP-1s for Obesity in Texas
or Saxenda). Amid the Biden administration’s recent proposal to expand obesity drug coverage under Medicare and Medicaid, experts at Real Chemistry examined which state Medicaid programs ...